DK3577225T1 - Optimized vector for delivery in microbial populations - Google Patents
Optimized vector for delivery in microbial populations Download PDFInfo
- Publication number
- DK3577225T1 DK3577225T1 DK18705108.1T DK18705108T DK3577225T1 DK 3577225 T1 DK3577225 T1 DK 3577225T1 DK 18705108 T DK18705108 T DK 18705108T DK 3577225 T1 DK3577225 T1 DK 3577225T1
- Authority
- DK
- Denmark
- Prior art keywords
- delivery
- microbial populations
- optimized vector
- optimized
- vector
- Prior art date
Links
- 230000000813 microbial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17305126.9A EP3358015A1 (en) | 2017-02-03 | 2017-02-03 | Optimized vector for delivery in microbial populations |
PCT/EP2018/052662 WO2018141907A1 (en) | 2017-02-03 | 2018-02-02 | Optimized vector for delivery in microbial populations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3577225T1 true DK3577225T1 (da) | 2020-06-29 |
Family
ID=58428223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18705108.1T DK3577225T1 (da) | 2017-02-03 | 2018-02-02 | Optimized vector for delivery in microbial populations |
Country Status (10)
Country | Link |
---|---|
US (5) | US11905516B2 (da) |
EP (2) | EP3358015A1 (da) |
JP (2) | JP7250702B2 (da) |
KR (1) | KR102563835B1 (da) |
CN (1) | CN110268062A (da) |
CA (1) | CA3049511A1 (da) |
DE (1) | DE18705108T1 (da) |
DK (1) | DK3577225T1 (da) |
IL (2) | IL312476A (da) |
WO (1) | WO2018141907A1 (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3358015A1 (en) | 2017-02-03 | 2018-08-08 | Eligo Bioscience | Optimized vector for delivery in microbial populations |
US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
WO2020106158A1 (en) * | 2018-11-20 | 2020-05-28 | Acd Pharmaceuticals As | Serratia liquefaciens variant |
CN110129279B (zh) * | 2019-04-24 | 2022-02-18 | 昆明理工大学 | 一种粪肠球菌噬菌体及其分离、纯化、富集和应用 |
US20220233615A1 (en) * | 2019-05-21 | 2022-07-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bacteriophages for the treatment of tuberculosis |
CN110484513B (zh) * | 2019-08-23 | 2021-04-16 | 中国水产科学研究院黑龙江水产研究所 | 噬菌体pAhMJG及其在治疗嗜水气单胞菌引发的鱼类疾病中的应用 |
CN110904054A (zh) * | 2019-09-29 | 2020-03-24 | 中国科学院大学 | 一种沙门氏菌噬菌体see-1及其应用 |
WO2021126344A2 (en) * | 2019-10-03 | 2021-06-24 | President And Fellows Of Harvard College | Compositions and methods comprising engineered bacteriophage |
CN111088233A (zh) * | 2020-01-08 | 2020-05-01 | 中国科学院大学 | 一株痢疾志贺氏菌噬菌体sse1及其应用 |
CN111041130B (zh) * | 2020-03-13 | 2020-06-12 | 圣湘生物科技股份有限公司 | 检测病原体的组合物、试剂盒及方法 |
JP2023520729A (ja) * | 2020-04-08 | 2023-05-18 | エリゴ・バイオサイエンス | マイクロバイオーム関連疾患又は障害を防止、治療、又は治癒するための、マイクロバイオームの遺伝子療法による微生物叢機能のモジュレーション |
CN111973616A (zh) * | 2020-07-15 | 2020-11-24 | 中山大学 | 副溶血弧菌23S rRNA和/或其保守序列VP13在提高鱼类免疫力中的应用 |
CN112011563A (zh) * | 2020-09-14 | 2020-12-01 | 安徽农业大学 | 一种基于ai-2群体感应自诱导蛋白表达载体及应用 |
CN112063593B (zh) * | 2020-09-17 | 2021-08-31 | 扬州大学 | 一种致病性弧菌噬菌体VmYZU10474及其应用 |
WO2022140630A1 (en) * | 2020-12-23 | 2022-06-30 | Locus Biosciences, Inc. | Altering the normal balance of microbial populations |
CN113201506B (zh) * | 2021-06-07 | 2023-03-21 | 西南医科大学 | 一株高效裂解碳青霉烯耐药肺炎克雷伯菌噬菌体及其应用 |
WO2023158883A2 (en) * | 2022-02-19 | 2023-08-24 | Salvitus, Inc. | Probiotic vaccines and related methods of use |
CN114634888B (zh) * | 2022-03-04 | 2023-05-26 | 中南大学 | 一种铊氧化菌、微生物菌剂及其应用 |
TW202400783A (zh) * | 2022-04-28 | 2024-01-01 | 日商安斯泰來製藥股份有限公司 | 噬菌體 |
CN116024146B (zh) * | 2023-03-28 | 2023-06-27 | 中国农业大学 | 一株高抗菌活性枯草芽孢杆菌及其发酵条件优化 |
KR102666595B1 (ko) * | 2023-06-16 | 2024-05-16 | ㈜에스에이치랩 | 박테리오파지 유래 펩타이드를 포함하는 피부 주름 개선용 생분해성 고분자 필러 및 이의 제조방법 |
CN116676324B (zh) * | 2023-07-28 | 2023-10-27 | 四川大学华西医院 | 基于Kil蛋白构建释放抗肿瘤效应蛋白的***及方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3442774B2 (ja) * | 1991-07-01 | 2003-09-02 | バーレックス ラボラトリーズ,インコーポレイティド | 新規な突然変異誘発法および組成物 |
CA2444819A1 (en) * | 2001-04-19 | 2002-10-31 | Biophage, Inc. | Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
WO2013049121A2 (en) * | 2011-09-26 | 2013-04-04 | Sample6 Technologies, Inc. | Recombinant phage and methods |
WO2014124226A1 (en) | 2013-02-07 | 2014-08-14 | The Rockefeller University | Sequence specific antimicrobials |
DK3041498T3 (da) * | 2013-09-05 | 2022-05-09 | Massachusetts Inst Technology | Afstemning af mikrobielle populationer med programmerbare nukleaser |
WO2017053327A1 (en) * | 2015-09-24 | 2017-03-30 | San Diego State University (Sdsu) Foundation , Dba San Diego State University Research Foundation | Antibacterial and protective bacteriophage formulations and methods for making and using them |
EP3358015A1 (en) * | 2017-02-03 | 2018-08-08 | Eligo Bioscience | Optimized vector for delivery in microbial populations |
-
2017
- 2017-02-03 EP EP17305126.9A patent/EP3358015A1/en not_active Withdrawn
-
2018
- 2018-02-02 KR KR1020197025232A patent/KR102563835B1/ko active IP Right Grant
- 2018-02-02 IL IL312476A patent/IL312476A/en unknown
- 2018-02-02 EP EP18705108.1A patent/EP3577225A1/en active Pending
- 2018-02-02 CN CN201880010298.0A patent/CN110268062A/zh active Pending
- 2018-02-02 JP JP2019563676A patent/JP7250702B2/ja active Active
- 2018-02-02 IL IL267932A patent/IL267932B1/en unknown
- 2018-02-02 WO PCT/EP2018/052662 patent/WO2018141907A1/en unknown
- 2018-02-02 DE DE18705108.1T patent/DE18705108T1/de active Pending
- 2018-02-02 US US16/482,458 patent/US11905516B2/en active Active
- 2018-02-02 DK DK18705108.1T patent/DK3577225T1/da unknown
- 2018-02-02 CA CA3049511A patent/CA3049511A1/en active Pending
-
2019
- 2019-07-31 US US16/527,762 patent/US10808254B2/en active Active
-
2020
- 2020-09-10 US US17/017,111 patent/US11078490B2/en active Active
-
2021
- 2021-06-23 US US17/356,079 patent/US11946056B2/en active Active
-
2023
- 2023-03-20 JP JP2023044675A patent/JP2023073319A/ja active Pending
-
2024
- 2024-02-21 US US18/582,939 patent/US20240218380A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2020506726A (ja) | 2020-03-05 |
IL267932B1 (en) | 2024-06-01 |
US20200248192A1 (en) | 2020-08-06 |
WO2018141907A1 (en) | 2018-08-09 |
IL267932A (en) | 2019-09-26 |
KR20190115019A (ko) | 2019-10-10 |
US20240218380A1 (en) | 2024-07-04 |
US11905516B2 (en) | 2024-02-20 |
US11078490B2 (en) | 2021-08-03 |
JP7250702B2 (ja) | 2023-04-03 |
EP3358015A1 (en) | 2018-08-08 |
CA3049511A1 (en) | 2018-08-09 |
DE18705108T1 (de) | 2020-08-13 |
KR102563835B1 (ko) | 2023-08-03 |
CN110268062A (zh) | 2019-09-20 |
US10808254B2 (en) | 2020-10-20 |
US11946056B2 (en) | 2024-04-02 |
US20200040346A1 (en) | 2020-02-06 |
IL312476A (en) | 2024-06-01 |
EP3577225A1 (en) | 2019-12-11 |
US20210380993A1 (en) | 2021-12-09 |
US20200399645A1 (en) | 2020-12-24 |
JP2023073319A (ja) | 2023-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3577225T1 (da) | Optimized vector for delivery in microbial populations | |
IL283877A (en) | Changing bacterial populations and microbiota adaptation | |
IL283280A (en) | Providing bacteria-based proteins | |
HK1256138A1 (zh) | 基於細菌的蛋白遞送 | |
FI3753929T3 (fi) | Dimeerisiä varjoaineita | |
PL3423365T3 (pl) | System dostarczania towarów | |
DK3350765T3 (da) | Selvdrevet forsyningsgode-leveringssystem | |
DK3288955T3 (da) | Bortezomib-baseret afgivelsessystem | |
ZA201906134B (en) | Improvements in fans | |
DK3206733T3 (da) | Leveringssystem og driftsmodus | |
HK1259380A1 (zh) | Ii型抗cd20抗體用於器官移植中 | |
PT3795171T (pt) | Transferrina para utilização em transplante renal | |
IL275451A (en) | Neurotoxins for use in reducing scarring | |
DK3380487T3 (da) | Additivsystemer til anvendelse i proteinpegylering | |
GB201721312D0 (en) | Improvements in transplantation | |
IT201700043588A1 (it) | Consegna espressa in giornata | |
GB201611041D0 (en) | Consignment delivery tracking |